Q: Hi guys. How do you view the fact that HCG announced in the Q3 earnings call that it is planning on continuing a normal course issuer bid going forward, yet the CEO Solloway has sold 40,000 shares in the past week? Realize that he still owns approx. 3.5 M shares. Do you guys view this as cause for concern or just bad optics?
Thank you
Thank you